Biodexa Pharmaceuticals Plc (BDRX)
$0.35-7.89%Close
BUYCRISIS · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $261,140
- Beta
- 1.28
- P/E (TTM)
- -0.01
- Short % float
- 3.03%
- Days to cover
- 1.0
- SI change
- -93.2%
- 1W
- -41.67%
- 1M
- -68.75%
- vs SPY 1W
- -41.53%
- vs SPY 1M
- -71.26%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BDRX?
- LOPJLB’s latest quantitative signal on Biodexa Pharmaceuticals Plc (BDRX) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is BDRX in?
- Biodexa Pharmaceuticals Plc (BDRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Biodexa Pharmaceuticals Plc (BDRX) do?
- Biodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of products. Founded in 2000 and headquartered in Cardiff, United Kingdom, the company was formerly known as Midatech Pharma plc until its rebranding in March 2023. Its research and development efforts are focused on addressing significant unmet medical needs…